Alopecia secondary to anti-tumor necrosis factor-alpha therapy

Anais Brasileiros de Dermatologia

Volumn 90, Issue 2, 2015, Pages 232-235

  Ribeiro, Lara Beatriz Prata ^a   Rego, Juliana Carlos Gonçalves ^b   Duque Estrada, Bruna ^b   Bastos, Paula Raso ^b   Maceira, Juan Manuel Piñeiro ^c   Sodré, Celso Tavares ^b,d  

^a ABC   (Brazil)

^b Instituto de Dermatologia Prof Rubem David Azulay da Santa Casa de Misericordia do Rio de Janeiro   (Brazil)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Alopecia; Alopecia areata; Dermoscopy; Psoriasis; Tumor necrosis factor alpha

Indexed keywords

BETAMETHASONE; CLOBETASOL; COAL TAR; CORTICOSTEROID; INFLIXIMAB; MOMETASONE FUROATE; TACROLIMUS; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALOPECIA; ARTICLE; CASE REPORT; CROHN DISEASE; DESQUAMATION; EPIDERMIS HYPERPLASIA; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; MALE; PARAKERATOSIS; REMISSION; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG ERUPTION; EPILUMINESCENCE MICROSCOPY; PATHOLOGY; PSORIASIS; SCALP;

ADOLESCENT; ADULT; ALOPECIA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; CROHN DISEASE; DERMOSCOPY; DRUG ERUPTIONS; FEMALE; HUMANS; INFLIXIMAB; MALE; PSORIASIS; SCALP; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84926320309     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/abd1806-4841.20153084     Document Type: Article

References (10)

1. Iborra M, Beltran B, Bastida G, Aguas M, Nos P. Infliximab and adalimumab-induced psoriasis in Crohn's disease: A paradoxical side effect. J Crohns Colitis. 2011;5:157-61.
2. Doyle LA, Sperling LC, Baksh S, Lackey J, Thomas B, Vleugels RA, et al. Psoriatic alopecia/alopecia areata-like reactions secondary to anti-Tumor Necrosis Factor-α Therapy: A Novel Cause of Noncicatricial Alopecia. Am J Dermatopathol. 2011;33:161-6.
3. Collamer AN, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum. 2010;40:233-40.
4. Cullen G, Kroshinsky D, Cheifetz AS, Korzenik JR. Psoriasis associated with antitumor necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature. Aliment Pharmacol Ther. 2011;34:1318-27.
5. Medkour F, Babai S, Chanteloup E, Buffard V, Delchier JC, Le-Louet H. Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab. Gastroenterol Clin Biol. 2010;34:140-1.
6. Perman MJ, Lovell DJ, Denson LA, Farrell MK, Lucky AW. Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children. Pediatr Dermatol. 2012;29:454-9.
7. Peckham SJ, Sloan SB, Elston DM. Histologic features of alopecia areata other than peribulbar lymphocytic infiltrates. J Am Acad Dermatol. 2011;65:615-20.
8. Bardazzi F, Fanti PA, Orlandi C, Chieregato C, Misciali C. Psoriatic scarring alopecia: observations in four patients. Int J Dermatol. 1999;38:765-8.
9. James WD, Berger TG, Elston DM. Andrews diseases of the skin. 10th ed. Philadelphia: Saunders/Elsevier; 2006. p. 749-51.
10. Ferran M, Calvet J, Almirall M, Pujol RM, Maymó J. Alopecia areata as another immune-mediated disease developed in patients treated with tumor necrosis factor- α blocker agents. Report of five cases and review of the literature. J Eur Acad Dermatol Venereol. 2011;25:479-84.